- Tytuł:
- Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial
- Autorzy:
- Źródło:
- In The Lancet Infectious Diseases October 2022 22(10):1444-1454
Czasopismo naukowe